In this study, we want to find out if an investigational treatment, P-CD19CD20-ALLO1, is safe and will help treat people with some B-cell malignancies. The study is also being done to determine what dose is tolerated and whether it is effective in treating some B cell malignancies.
Thank you for your interest, but this study will start enrolling soon.
United States (Nationwide)
Natalie Grover
LCCC - Clinical Trials
Clinical or Medical
Interventional
Cancer (Lymphoma)
23-2028
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
